GVG-NET
Latest News
The GVG-NET initiative, led by Dr. Christopher Bayliss, has received funds from the Medical Research Council UK to organise a workshop for the development of the initiative.
“GVG-NET is a promising initiative, addressing the critical issue of understanding how bacterial pathogens mutate their genetic code, and the impact this has on the bacteria’s antibiotic resistance and pathogenesis. EuroBioForum was a first step in bringing together the researchers involved, with representatives from the pharmaceutical industry and funding organisations to provide input and advice. The support from the MRC will build on this first step, to facilitate interested parties in the process of developing GVG-NET.”– Dr. Mark Palmer, Head of International Policy, MRC. |
What is GVG-NET?
Combating Bacterial Pathogenesis and Antibiotic Resistance
Many bacterial pathogens are endemic within Europe and are responsible for a significant disease burden which includes meningitis, gastric ulcers and gasteroenteritis. Recent years have seen an elevated incidence of new diseases such as MRSA but also old ones such as Tuberculosis. GVG-NET aims to understand the mechanisms by which bacterial pathogens change (‘mutate’) their genetic code and to characterise the distribution of strains with differences in these mutational mechanisms. This data will be essential for researchers in both Europe and world-wide for combating antibiotic resistance, pathogenesis and the spread of bacterial pathogens and may lead to new therapeutic targets for addressing these pathogens.